ARTICLE | Clinical News
Kadcyla trastuzumab emtansine: Phase III data
December 22, 2014 8:00 AM UTC
Top-line data from the 3-arm, double-blind, placebo-controlled, international Phase III MARIANNE (BO22589) trial in 1,095 previously untreated patients with HER2-positive advanced breast cancer showed...